Blues in the Brain and Beyond: Molecular Bases of Major Depressive Disorder and Relative Pharmacological and Non-Pharmacological Treatments
Despite the extensive research conducted in recent decades, the molecular mechanisms underlying major depressive disorder (MDD) and relative evidence-based treatments remain unclear. Various hypotheses have been successively proposed, involving different biological systems. This narrative review aim...
Main Authors: | Elisabetta Maffioletti, Alessandra Minelli, Daniela Tardito, Massimo Gennarelli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/11/9/1089 |
Similar Items
-
Novel Pharmacological Approaches to the Treatment of Depression
by: Elias Elias, et al.
Published: (2022-01-01) -
The pharmacological management of depression – Update 2017
by: Elzbieta Osuch, et al.
Published: (2017-03-01) -
The dynamic interaction between symptoms and pharmacological treatment in patients with major depressive disorder: the role of network intervention analysis
by: Claudia Savia Guerrera, et al.
Published: (2023-11-01) -
Astroglial Connexins Inactivation Increases Relapse of Depressive-like Phenotype after Antidepressant Withdrawal
by: Benjamin Portal, et al.
Published: (2022-10-01) -
Research progress of non-monoamine antidepressants
by: Huan Zhang, et al.
Published: (2021-12-01)